Literature DB >> 33146871

Association between chronic inflammatory demyelinating polyneuropathy and gastrointestinal malignancies.

Adnan Malik1, Rani Berry2, Brian M Fung3, James H Tabibian4,5.   

Abstract

Chronic inflammatory demyelinating polyneuropathy (CIDP) is an uncommon and under-recognized immune-mediated disorder of the peripheral nervous system. It is associated with both infectious and non-infectious etiologies and presents in several variant forms. In rare instances, CIDP has been reported in association with gastrointestinal (esophageal, hepatic, colorectal, and pancreatic) malignancies. The diagnosis of malignancy is typically preceded by weeks to months by that of CIDP, though the inverse may also be seen. As with other etiologies of CIDP, cases associated with gastrointestinal malignancies are often treated with corticosteroids, intravenous immunoglobulins, and/or plasma exchange, with improvement or resolution of neurological symptoms in the majority of cases. In this review, we provide a practical overview of CIDP, with an emphasis on recognizing the clinical association between CIDP and gastrointestinal malignancies.

Entities:  

Keywords:  Autoimmune disease; Carcinoma; Gastrointestinal; Peripheral neuropathy

Mesh:

Substances:

Year:  2020        PMID: 33146871     DOI: 10.1007/s12328-020-01281-7

Source DB:  PubMed          Journal:  Clin J Gastroenterol        ISSN: 1865-7265


  93 in total

1.  Chronic inflammatory demyelinating polyradiculoneuropathy. A clinical and electrophysiological study of 92 cases.

Authors:  P A McCombe; J D Pollard; J G McLeod
Journal:  Brain       Date:  1987-12       Impact factor: 13.501

2.  Distinguishing acute-onset CIDP from fluctuating Guillain-Barre syndrome: a prospective study.

Authors:  L Ruts; J Drenthen; B C Jacobs; P A van Doorn
Journal:  Neurology       Date:  2010-04-28       Impact factor: 9.910

Review 3.  Chronic inflammatory demyelinating polyneuropathy as an autoimmune disease.

Authors:  Yhojan Rodríguez; Nikhil Vatti; Carolina Ramírez-Santana; Christopher Chang; Oscar Mancera-Páez; M Eric Gershwin; Juan-Manuel Anaya
Journal:  J Autoimmun       Date:  2019-05-06       Impact factor: 7.094

4.  Overview of the pathogenesis and treatment of chronic inflammatory demyelinating polyneuropathy with intravenous immunoglobulins.

Authors:  Mohamed Mahdi-Rogers; Yusuf A Rajabally
Journal:  Biologics       Date:  2010-03-24

5.  Patients with chronic inflammatory demyelinating polyneuropathy initially diagnosed as Guillain-Barré syndrome.

Authors:  Masaaki Odaka; Nobuhiro Yuki; Koichi Hirata
Journal:  J Neurol       Date:  2003-08       Impact factor: 4.849

6.  Original research: Second IVIg course in Guillain-Barré syndrome with poor prognosis: the non-randomised ISID study.

Authors:  Christine Verboon; Bianca van den Berg; David R Cornblath; Esmee Venema; Kenneth C Gorson; Michael P Lunn; Hester Lingsma; Peter Van den Bergh; Thomas Harbo; Kathleen Bateman; Yann Pereon; Søren H Sindrup; Susumu Kusunoki; James Miller; Zhahirul Islam; Hans-Peter Hartung; Govindsinh Chavada; Bart C Jacobs; Richard A C Hughes; Pieter A van Doorn
Journal:  J Neurol Neurosurg Psychiatry       Date:  2019-10-05       Impact factor: 10.154

Review 7.  Chronic inflammatory demyelinating polyradiculoneuropathy: from bench to bedside.

Authors:  Amanda C Peltier; Peter D Donofrio
Journal:  Semin Neurol       Date:  2012-11-01       Impact factor: 3.420

8.  Chronic inflammatory demyelinating polyneuropathy and malignancy: A systematic review.

Authors:  Yusuf A Rajabally; Shahram Attarian
Journal:  Muscle Nerve       Date:  2017-12-20       Impact factor: 3.217

9.  Incidence and Prevalence of Chronic Inflammatory Demyelinating Polyradiculoneuropathy: A Systematic Review and Meta-Analysis.

Authors:  Merel C Broers; Carina Bunschoten; Daan Nieboer; Hester F Lingsma; Bart C Jacobs
Journal:  Neuroepidemiology       Date:  2019-01-22       Impact factor: 3.282

Review 10.  Chronic inflammatory demyelinating polyradiculoneuropathy: from pathology to phenotype.

Authors:  Emily K Mathey; Susanna B Park; Richard A C Hughes; John D Pollard; Patricia J Armati; Michael H Barnett; Bruce V Taylor; P James B Dyck; Matthew C Kiernan; Cindy S-Y Lin
Journal:  J Neurol Neurosurg Psychiatry       Date:  2015-02-12       Impact factor: 10.154

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.